Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

De Götzen S.R.L. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

239 daysmedian FDA review time
303 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K231055x-mind dc (under trademark Acteon), Owandy-RX DC (under tradDe Götzen S.R.L.2023-12-282590
K203374X-MIND prime (under trade mark Acteon), I-MAX (under trade mDe Götzen S.R.L.2021-02-05810
K201382X-MIND prime 3D (under trademark Acteon), I-MAX 3D (under trDe Gotzen S.R.L.2020-11-181760
K191719X-MIND TriumDe Gotzen S.R.L.2020-02-202390
K192165Acteon Imaging SuiteDe Gotzen S.R.L.2020-02-111860
K160166X-MIND triumDe Gotzen S.R.L.2016-11-152930
K132378X-MIND UNITYDe Gotzen S.R.L.2014-05-303030

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda